Literature DB >> 7859944

Normal effect of insulin to stimulate leg blood flow in NIDDM.

F Dela1, J J Larsen, K J Mikines, H Galbo.   

Abstract

In patients with non-insulin-dependent diabetes mellitus (NIDDM), a decreased effect of insulin in stimulating leg blood flow (LBF) has been reported. We reinvestigated the effect of insulin on LBF and validated our data by use of other measures. Eight healthy men (control group) and seven men with NIDDM were studied (age 59 +/- 1 and 58 +/- 3 years, weight 83 +/- 3 and 86 +/- 6 kg, fat-free mass 66 +/- 1 and 64 +/- 3 kg, respectively [mean +/- SE, all P > 0.05]; body mass index 26 +/- 1 and 29 +/- 1 kg/m2, fasting plasma insulin 72 +/- 7 and 187 +/- 22 pmol/l, fasting plasma glucose 5.8 +/- 0.2 and 10.2 +/- 1.7 mmol/l [all P < 0.05]). A three-step hyperinsulinemic glucose clamp (ambient glucose level) was performed, combined with catheterization of an artery and both femoral veins. Expiratory air was collected, LBF was measured by thermodilution, and blood was sampled and analyzed for oxygen content. Insulin concentration was increased to 416 +/- 22 and 509 +/- 43 (step I), 1,170 +/- 79 and 1,299 +/- 122 (step II), and 15,936 +/- 1,126 and 16,524 +/- 1,916 (step III) pmol/l in control and NIDDM subjects, respectively (P > 0.05). LBF increased similarly (P > 0.05) in the two groups (from 287 +/- 23 and 302 +/- 12 [basal] to 308 +/- 31 and 362 +/- 9 [I], 371 +/- 29 and 409 +/- 17 [II], and 434 +/- 32 and 472 +/- 29 [III] ml.min-1.leg-1 in control and NIDDM subjects, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859944     DOI: 10.2337/diab.44.2.221

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Resistance training and insulin action in humans: effects of de-training.

Authors:  J L Andersen; P Schjerling; L L Andersen; F Dela
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

2.  Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

Authors:  T Utriainen; P Nuutila; T Takala; P Vicini; U Ruotsalainen; T Rönnemaa; T Tolvanen; M Raitakari; M Haaparanta; O Kirvelä; C Cobelli; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 3.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 4.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

5.  A case of insulin edema with inappropriate hyperaldosteronism.

Authors:  G Kalambokis; A Tsatsoulis; G Economou; E V Tsianos
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 6.  Insulin action in muscle and adipose tissue in type 2 diabetes: The significance of blood flow.

Authors:  Vaia Lambadiari; Konstantinos Triantafyllou; George D Dimitriadis
Journal:  World J Diabetes       Date:  2015-05-15

7.  Relationship between limb and muscle blood flow in man.

Authors:  M Raitakari; P Nuutila; U Ruotsalainen; M Teräs; E Eronen; H Laine; O T Raitakari; H Iida; M J Knuuti; H Yki-Järvinen
Journal:  J Physiol       Date:  1996-10-15       Impact factor: 5.182

8.  Effects of strength training on muscle lactate release and MCT1 and MCT4 content in healthy and type 2 diabetic humans.

Authors:  Carsten Juel; Mads K Holten; Flemming Dela
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

9.  Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography.

Authors:  P Nuutila; M Raitakari; H Laine; O Kirvelä; T Takala; T Utriainen; S Mäkimattila; O P Pitkänen; U Ruotsalainen; H Iida; J Knuuti; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.